Oscient Pharmaceuticals Corp. (OSCI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tara Cobble who wrote (44)	7/23/1996 6:10:00 AM
From: Joseph wang	of 1154

Thanks for your information regarding GENE. NIH : National Institute of Health. Responsible for funding and conducting research both academic and industrial. They also help set up guidelines for research and safety standards (as does the Center for Disease Control [CDC]). NIH HQ is located in Maryland (?) feel free to correct me if I am wrong. NIH has granted GENE $40 million cash for research. As for EPS. Unfortunately, from a technical standpoint, I don't see GENE trading much higher than $11-12 unless market conditions become incredibly bullish. Also, EPS is only expected to be 6 cents and 4 cents for the all of 1996 and all of 1997??? is there EPS for 1998? EPS must be at least 30 cents to $1.00 for 1998 for the stock to even trade near $25/share. Does anyone see it doing that? I would like to know why GENE isn't making substantial earnings. Is the company expecting to see substantial future earnings (i.e. 1998 and beyond?). We can all do technical analysis and determine where the stock SHOULD be trading and alot of math to determine moving averages, PEs, etc....but I would like to know if anyone has any real information regarding how the company feels about how it is doing. (i.e. the opinions expressed by analysts and traders are rather irrelevant for the LONGTERM.) ____________________ From comparing data among the others: HGSI, INCY, MYGN, MLNM, and SQNA...I believe GENE may be the underperformer (based on fundamentals). HGSI, INCY, and SQNA are leaders at the moment. HGSI and INCY are both trading expensively. SQNA (after issuing stock) is trading at a fairly cheap level ($15 3/4-17). INCY needs to come down to the lower-mid 30s. MLNM (millennium) is trading expensively in the $15-16 range...will be a good buy at $11-13.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next